Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
PROC Procaps
4.040+0.040+1.00%
Close
02/08 16:00 ET
High
4.300
Open
4.190
Turnover
22.17K
Low
3.991
Pre Close
4.000
Volume
5.45K
Intraday
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Procaps Group (NASDAQ:PROC Investor Three-year Losses Grow to 58% as the Stock Sheds US$58m This Past Week
If you love investing in stocks you're bound to buy some losers. But the last three years have been particularly tough on longer term Procaps Group S.A. (NASDAQ:PROC) shareholders. Sadly for them, t
Procaps Group (NASDAQ:PROC) Shares Gap Up to $4.30
Procaps Group S.A. (NASDAQ:PROC – Get Rating)'s stock price gapped up prior to trading on Friday . The stock had previously closed at $4.30, but opened at $6.70. Procaps Group shares last traded at $
Procaps Group (NASDAQ:PROC) Trading 5.6% Higher
Procaps Group S.A. (NASDAQ:PROC – Get Rating) traded up 5.6% on Monday . The stock traded as high as $4.76 and last traded at $4.75. 7,148 shares were traded during trading, a decline of 87% from th
A Look At The Fair Value Of Procaps Group S.A. (NASDAQ:PROC)
Press Release: Procaps Announces Key Changes to the Board of Directors
Procaps Announces Key Changes to the Board of Directors International Corporate Executive and Attorney Alberto Eguiguren Correa Appointed to Board of Directors MIAMI and BARRANQUILLA, Colombia, Jan.
Procaps Group (NASDAQ:PROC) Shares Gap Up to $4.73
Procaps Group S.A. (NASDAQ:PROC – Get Rating) shares gapped up before the market opened on Thursday . The stock had previously closed at $4.73, but opened at $5.15. Procaps Group shares last traded a
5 Value Stocks In The Healthcare Sector
What are Value Stocks?A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be undervalued, as investors ar
Procaps Group (NASDAQ:PROC) Stock Price Up 11.9%
Procaps Group S.A. (NASDAQ:PROC – Get Rating) rose 11.9% during trading on Friday . The stock traded as high as $5.00 and last traded at $5.00. Approximately 432 shares traded hands during mid-day tr
Procaps Group (NASDAQ:PROC) Trading Down 3.4%
Procaps Group S.A. (NASDAQ:PROC – Get Rating)'s share price dropped 3.4% during trading on Wednesday . The stock traded as low as $4.52 and last traded at $4.52. Approximately 99 shares traded hands
Procaps Group Terminates Proposed Acquisition of Grupo Somar
03:17 AM EST, 01/04/2023 (MT Newswires) -- Procaps Group (PROC) said late Tuesday it terminated its proposed acquisition of Grupo Somar. The acquisition was already delayed due to an embargo issued by
Company Overview
More
Procaps Group SA is an international healthcare and pharmaceutical company. The firm is engaged in the developing of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies. It operates through the following segments: NextGel, Procaps Colombia, CAN, CASAND, and Diabetrics. The NextGel segment is involved in the manufacturing and distribution of prescription and over-the-counter pharmaceutical products in USA, Brazil, and Colombia. The Procaps Colombia segment is focused on the manufacturing and distribution of prescription and over-the-counter pharmaceutical products in Colombia. The CAN segment deals with the manufacturing and distribution of prescription and over-the-counter pharmaceutical products in Northern Central America: Salvador, Guatemala, Nicaragua, and Honduras. The CASAND segment offers pharmaceutical products in Southern Central America that include Panama and Costa Rica, and the North Andes District that include Ecuador, Peru, and Bolivia. The Diabetrics segment consists of the diabetes solutions and chronic disease management tool. The company was founded by Ruben Minski in 1977 and is headquartered in Luxembourg.
CEO： Mr. Ruben Minski
Market： NASDAQ
Listing Date： 12/09/2019
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet